'%20d='m0%200%2016%2011h61%2061%2061%2061%2060L47%2037h61%2061%2060%2061L16%2063h61%2061%2061%2061%2060L47%2089h61%2061%2060%2061L16%20115h61%2061%2061%2061%2060L47%20141h61%2061%2060%2061L16%20166h61%2061%2061%2061%2060L47%20192h61%2061%2060%2061L16%20218h61%2061%2061%2061%2060z'/%3e%3c/svg%3e)
About
Eduardo Hariton holds a job title that none of the other four San Ramon physicians on this page has: he is US Fertility’s Senior Vice President of Clinical Growth and Innovation and a Managing Director of the network’s Innovation Fund — the corporate side of the group RSC belongs to. His clinical day still runs at RSC’s exam rooms in San Ramon and Oakland, which is the combination the role implies: a practicing reproductive endocrinologist who also works on how fertility clinics adopt technology.
The training path is straight down the East Coast academic corridor and back. He took his medical degree at Harvard Medical School, his obstetrics and gynecology residency at Brigham and Women’s Hospital and Massachusetts General Hospital in Boston, and his reproductive endocrinology and infertility fellowship at UCSF. Alongside the clinical credentials he completed an MBA at Harvard Business School. He is board-certified in both obstetrics and gynecology and in reproductive endocrinology and infertility, and he consults in Spanish as well as English.
His published work is where the two halves meet. His thesis research applied artificial intelligence to improving IVF outcomes and drew recognition within the field, and his RSC profile counts more than 70 research publications, abstracts and presentations. The clinical interests listed for him are polycystic ovary syndrome, recurrent pregnancy loss, egg freezing, diminished ovarian reserve and uterine fibroids — the diagnoses where embryo selection and protocol choice carry the most weight.
Clinical Expertise
- PCOS: stimulation strategy for ovaries that respond unpredictably — the commonest reason an IVF cycle needs re-planning mid-course
- Recurrent pregnancy loss: working through cause evaluation rather than moving straight to the next transfer
- Egg freezing and fertility preservation: protocol design and honest counseling about what a frozen egg bank can and cannot buy back
- Diminished ovarian reserve: cycles where the response, not the technique, is the limiting factor
- Uterine fibroids: deciding when a fibroid is the reason a transfer failed and when it is an innocent bystander
- Artificial intelligence in IVF: his thesis area, and the reason his name appears on the innovation side of a national fertility network as well as in a clinic schedule
Why Choose Dr. Eduardo Hariton
He reads the literature and helps write it. Seventy-plus publications, abstracts and presentations is not a marketing line; it is the volume of a physician who stays in research while practicing, and his named research area — machine-assisted embryo assessment — is exactly the topic a patient comparing clinics will be asked to trust.
He can see the whole pathway. A reproductive endocrinologist who also runs innovation for a national network encounters protocols, lab technologies and cost structures at other clinics. For a patient deciding between a local program and a bigger platform, that comparative view is useful, particularly around add-on testing.
The training is verifiable and the credentials are current. Harvard Medical School, Brigham and Massachusetts General, UCSF fellowship, double board certification in OB/GYN and REI, with Spanish-language consultations at both Bay Area offices.
Professional Affiliations
Board certified in Obstetrics and Gynecology and in Reproductive Endocrinology and Infertility by the American Board of Obstetrics and Gynecology. Reproductive endocrinologist at Reproductive Science Center of the San Francisco Bay Area, practicing at the San Ramon and Oakland offices. Senior Vice President of Clinical Growth and Innovation at US Fertility, the network RSC belongs to, and a Managing Director of the US Fertility Innovation Fund. No society memberships are published in the sources reviewed for this page.
Suitable For
- PCOS patients: a named clinical focus, and the diagnosis where stimulation protocols diverge most between clinics
- Recurrent pregnancy loss: listed among his areas of expertise, with research credentials behind the evaluation side of that work
- Diminished ovarian reserve: patients whose protocol has to be built around a low response
- Patients weighing technology-assisted embryo selection: the one physician on this page whose own thesis is the application of AI to IVF outcomes
- Spanish-speaking patients: consultations available in Spanish